Profound Medical/$PROF
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Profound Medical
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Ticker
$PROF
Sector
Primary listing
Employees
142
Headquarters
Mississauga, Canada
Website
Profound Medical Metrics
BasicAdvanced
$185M
-
-$1.36
-
-
Price and volume
Market cap
$185M
52-week high
$8.32
52-week low
$3.76
Average daily volume
83K
Financial strength
Current ratio
4.178
Quick ratio
3.32
Total debt to equity
14.799
Interest coverage (TTM)
-217.68%
Profitability
EBITDA (TTM)
-41.541
Gross margin (TTM)
72.49%
Net profit margin (TTM)
-275.18%
Operating margin (TTM)
-295.38%
Effective tax rate (TTM)
0.03%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
-62.44%
Return on equity (TTM)
-124.49%
Valuation
Price to revenue (TTM)
12.652
Price to book
8.06
Price to tangible book (TTM)
8.09
Price to free cash flow (TTM)
-4.821
Free cash flow yield (TTM)
-20.74%
Free cash flow per share (TTM)
-1.292
Growth
Revenue change (TTM)
67.94%
Earnings per share change (TTM)
2.07%
3-year revenue growth (CAGR)
30.57%
3-year earnings per share growth (CAGR)
-1.28%
10-year earnings per share growth (CAGR)
-16.31%
What the Analysts think about Profound Medical
Analyst ratings (Buy, Hold, Sell) for Profound Medical stock.
Profound Medical Financial Performance
Revenues and expenses
Profound Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Profound Medical stock?
Profound Medical (PROF) has a market cap of $185M as of November 19, 2025.
What is the P/E ratio for Profound Medical stock?
The price to earnings (P/E) ratio for Profound Medical (PROF) stock is 0 as of November 19, 2025.
Does Profound Medical stock pay dividends?
No, Profound Medical (PROF) stock does not pay dividends to its shareholders as of November 19, 2025.
When is the next Profound Medical dividend payment date?
Profound Medical (PROF) stock does not pay dividends to its shareholders.
What is the beta indicator for Profound Medical?
Profound Medical (PROF) does not currently have a Beta indicator.